Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-κB activation in U937 cells

Life Sciences

Volumn 78, Issue 25, 2006, Pages 2937-2943

  Jang, Seon Il ^a   Kim, Young Jun ^a   Kim, Hyoung Jin ^b   Lee, Jeong Chi ^a   Kim, Hong Yong ^a   Kim, Youn Chul ^b   Yun, Young gab ^b   Yu, Hyeon Hee ^b   You, Yong Ouk ^b  

^a Seojeong College University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Artemisia capillaris; Interleukin 8; Monocyte chemotactic protein 1; Nuclear factor kappaB (NF B); Scoparone

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; SCOPARONE;

ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MONOCYTE; PHOSPHORYLATION; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; CHEMOKINE CCL2; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-8; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; TETRADECANOYLPHORBOL ACETATE;

ARTEMISIA CAPILLARIS; ASTERACEAE;

EID: 33646177532     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.11.020     Document Type: Article

References (34)

1. Anto R.J., Mukhopadhyay A., Shishodia S., Gairola C.G., and Aggarwal B.B. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 23 (2002) 1511-1518
2. Ashikawa K., Majumdar S., Banerjee S., Bharti A.C., Shishodia S., and Aggarwal B.B. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. Journal of Immunology 169 (2002) 6490-6497
3. Chang H.M., and But P.P.H. Pharmacology and applications of Chinese materia medica. World Scientific, Singapore (1987) 867-871
4. Chaturvedi M.M., Mukhopadhyay A., and Aggarwal B.B. Assay for redox-sensitive transcription factor. Methods in Enzymology 319 (2000) 585-602
5. Clark-Lewis I., Kim K.S., Rajarathnam K., Gong J.H., Dewald B., Moser B., Baggiolini M., and Sykes B.D. Structure-activity relationships of chemokines. Journal of Leukocyte Biology 57 (1995) 703-711
6. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovascular Research 53 (2002) 31-47
7. Haddad J.J., Safieh-Garabedian B., Saade N.E., and Land S.C. The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-kappa B targeting in the alveolar epithelium. British Journal of Pharmacology 133 (2001) 49-60
8. Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Droge W., and Schmitz M.L. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β. The Journal of Biological 273 (1998) 1288-1297
9. Huang H.C., Chu S.H., and Chao P.D. Vasorelaxants form Chinese herbs, emodin and scoparone, possess immunosuppressive properties. European Journal of Pharmacology 198 (1991) 211-213
10. Huang H.C., Lee C.R., Weng Y.I., Lee M.C., and Lee Y.T. Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. European Journal of Pharmacology 218 (1992) 123-128
11. Huang H.C., Huang Y.L., Chang J.H., Chen C.C., and Lee Y.T. Possible mechanism of immunosuppressive effect of scoparone (6,7-dimethoxycoumarin). European Journal of Pharmacology 217 (1992) 143-148
12. Jang S.I., Kim Y.J., Lee W.Y., Kwak K.C., Baek S.H., Kwak G.B., Yun Y.G., Kwon T.O., Chung H.T., and Chai K.Y. Scoparone from Artemisia capillaris inhibits the release of inflammatory mediators in RAW 264.7 cells upon stimulation cells by interferon-gamma plus LPS. Archives of Pharmacal Research 28 (2005) 203-208
13. Kang Y.J., Lee B.K., Lee Y.S., Seo H.G., Park M.K., Kim H.J., Pyo H.S., Chong W.S., Jung H.J., Yun-Choi H.S., Lee D.H., and Chang K.C. Suppression of tumor necrosis factor-alpha and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid. Biochemical Pharmacology 65 (2003) 457-464
14. Lee H.W., Ahn D.H., Crawley S.C., Li J.D., Gum Jr. J.R., Basbaum C.B., Fan N.Q., Szymkowski D.E., Han S.Y., Lee B.H., Sleisenger M.H., and Kim Y.S. Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa B. The Journal of Biological Chemistry 277 (2002) 32624-32631
15. MacDermott R.P. Chemokines in the inflammatory bowel diseases. Journal of Clinical Immunology 19 (1999) 266-272
16. Mackay C.R. Chemokines: immunology's high impact factors. Nature Immunology 2 (2001) 95-101
17. Majumdar S., and Aggarwal B.B. Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. Journal of Immunology 167 (2001) 2911-2920
18. Mukaida N., Harada A., and Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Reviews 9 (1998) 9-23
19. Mukhopadhyay A., Shishodia S., Suttles J., Brittingham K., Lamothe B., Nimmanapalli R., Bhalla K.N., and Aggarwal B.B. Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors. The Journal of Biological Chemistry 277 (2002) 30622-30628
20. Oh G.S., Pae H.O., Choi B.M., Jeong S., Oh H., Oh C.S., Rho Y.D., Kim D.H., Shin M.K., and Chung H.T. Inhibitory effects of the root cortex of Paeonia suffruticosa on interleukin-8 and macrophage chemoattractant protein-1 secretions in U937 cells. Journal of Ethnopharmacology 84 (2003) 85-89
21. Power C.A., and Proudfoot A.E. The chemokine system: novel broad-spectrum therapeutic targets. Current Opinion in Pharmacology 1 (2001) 417-424
22. Rakotoarison O., Rabenau I., Lobstein A., Um B.H., Schott C., Anton R., Randriantsoa A., and Andriantsitohaina R. Vasorelaxing properties and bio-guided fractionation of Cedrelopsis grevei. Planta Medica 69 (2003) 179-181
23. Rangan G.K., Wang Y., Tay Y.C., and Harris D.C. Inhibition of NFkappaB activation with antioxidants is correlated with reduced cytokine transcription in PTC. The American Journal of Physiology 277 (1999) F779-F789
24. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Research Communications 17 (1992) 221-237
25. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kB. Annual Review Cell Biology 10 (1994) 405-455
26. Stanimirovic D., and Satoh K. Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathology 10 (2000) 113-126
27. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., and Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutation Research 480-481 (2001) 243-268
28. Takao J., Yudate T., Das A., Shikano S., Bonkobara M., Ariizumi K., and Cruz P.D. Expression of NF-kappaB in epidermis and the relationship between NF-kappaB activation and inhibition of keratinocyte growth. The British Journal of Dermatology 148 (2003) 680-688
29. Valenciennes E., Smadja J., and Conan J.Y. Screening for biological activity and chemical composition of Euodia borbonica var. borbonica (Rutaceae), a medicinal plant in Reunion Island. Journal of Ethnopharmacology 64 (1999) 283-288
30. Wadsworth T.L., and Koop D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochemical Pharmacology 57 (1999) 941-949
31. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. The Journal of Biological Chemistry 269 (1994) 4705-4708
32. Zaninoni A., Imperiali F.G., Pasquini C., Zanella A., and Barcellini W. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia. Experimental Hematology 31 (2003) 185-190
33. Zhang X., Wang J.M., Gong W.H., Mukaida N., and Young H.A. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. Journal of Immunology 166 (2001) 7104-7111
34. Zhao B., Stavchansky S.A., Bowden R.A., and Bowman P.D. Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. American Journal Of Physiology. Cell Physiology 284 (2003) C1577-C1583